UBS AM’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-66,134
| Closed | -$397K | – | 2680 |
|
|
2017
Q4 | $397K | Sell |
66,134
-40,178
| -38% | -$241K | ﹤0.01% | 2046 |
|
|
2017
Q3 | $590K | Hold |
106,312
| – | – | ﹤0.01% | 1890 |
|
|
2017
Q2 | $493K | Buy |
106,312
+1,633
| +2% | +$7.58K | ﹤0.01% | 1892 |
|
|
2017
Q1 | $518K | Sell |
104,679
-18,556
| -15% | -$91.9K | ﹤0.01% | 1854 |
|
|
2016
Q4 | $1.37M | Buy |
123,235
+1,059
| +0.9% | +$11.8K | ﹤0.01% | 1441 |
|
|
2016
Q3 | $1.13M | Sell |
122,176
-26,201
| -18% | -$243K | ﹤0.01% | 1631 |
|
|
2016
Q2 | $942K | Sell |
148,377
-514
| -0.3% | -$3.26K | ﹤0.01% | 1681 |
|
|
2016
Q1 | $971K | Buy |
148,891
+50,333
| +51% | +$328K | ﹤0.01% | 1648 |
|
|
2015
Q4 | $799K | Sell |
98,558
-244,299
| -71% | -$1.98M | ﹤0.01% | 1831 |
|
|
2015
Q3 | $2.51M | Buy |
342,857
+56,558
| +20% | +$415K | ﹤0.01% | 1322 |
|
|
2015
Q2 | $2.93M | Buy |
+286,299
| New | +$2.93M | ﹤0.01% | 1237 |
|